Systemic neurochemical alterations in schizophrenic brain: Glutamate metabolism in focus

Neurochemical Research

Volumn 32, Issue 9, 2007, Pages 1434-1444

  Burbaeva, Gulnur Sh ^a   Boksha, Irina S ^a   Tereshkina, Elena B ^a   Savushkina, Olga K ^a   Starodubtseva, Lubov I ^a   Turishcheva, Marina S ^a   Mukaetova Ladinska, Elizabeta ^b  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Caudate nucleus; Cerebellum; Energy metabolism; Glia; Glutamate dehydrogenase isoenzymes; Glutamate metabolism; Glutamine synthetase; Glutamine synthetase like protein; Postmortem brain tissue; Prefrontal cortex; Schizophrenia; Systemic approach

Indexed keywords

CREATINE KINASE BB; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; ISOENZYME; MYELIN BASIC PROTEIN; TISSUE EXTRACT;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; AUTOPSY; BRAIN LEVEL; BRAIN TISSUE; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENERGY METABOLISM; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MENTAL PATIENT; NEUROCHEMISTRY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; AGED; BRAIN; CAUDATE NUCLEUS; CEREBELLAR CORTEX; CREATINE KINASE, BB FORM; ENERGY METABOLISM; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DEHYDROGENASE (NADP+); GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; HUMANS; MIDDLE AGED; MYELIN BASIC PROTEINS; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 34447640017     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9328-7     Document Type: Article

References (49)

1. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA (1992) Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiat 49:935-942
2. Fukuzako H (2001) Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. World J Biol Psychiatry 2:70-82
3. Gluck MR, Thomas RG, Davis KL, Haroutunian V (2002) Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry 159(7):1165-1173
4. Martin P, Albers M (1995) Cerebellum and schizophrenia: a selective review. Schizophr Bull 21(2):241-250
5. Mukaetova-Ladinska EB, Hurt J, Honer WG, Harrington CR, Wischik CM (2002) Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics. Neurosci Lett 317(3):161-165
6. Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS (2005) Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29(4):587-591
7. Bottmer C, Bachmann S, Pantel J, Essig M, Amann M, Schad LR, Magnotta V, Schroder J (2005) Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Res 140(3):239-250
8. Daskalakis ZJ, Christensen BK, Fitzgerald PB, Fountain SI, Chen R (2005) Reduced cerebellar inhibition in schizophrenia: a preliminary study. Am J Psychiatry 162(6):1203-1205
9. Honey GD, Pomarol-Clotet E, Corlett PR, Honey RA, McKenna PJ, Bullmore ET, Fletcher PC (2005) Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function. Brain 128(Pt 11):2597-2611
10. Konarski JZ, McIntyre RS, Grupp LA, Kennedy SH (2005) Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? J Psychiatry Neurosci 30(3):178-186
11. Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, prefrontal and limbic functions. Prog Brain Res 85:119-146
12. Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: Neural substrates of parallel processing. Trends Neurosci 13:266-270
13. Levitt JJ, Westin C-F, Nestor PG, Estepar RSJ, Dickey CC, Voglmaier MM, Seidman LJ, Kikinis R, Jolesz FA, McCarley RW, Shenton ME (2004) Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder. Biol Psychiatry 55:177-184
14. Levy R, Friedman HR, Davachi L, Goldman-Rakic PS (1997) Differential activation of the caudate nucleus in primates performing spatial and nonspatial working memory tasks. J Neurosci 17(10):3870-3882
15. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL (2000) Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 48:99-109
16. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004) Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67(2-3):269-275
17. Woo TU, Crowell AL (2005) Targeting synapses and myelin in the prevention of schizophrenia. Schizophr Res 73(2-3):193-207
18. Walterfang M, Wood SJ, Velakoulis D, Copolov D, Pantelis C (2005) Diseases of white matter and schizophrenia-like psychosis. Aust NZ J Psychiatry 39(9):746-756
19. Fatemi SH, Laurence JA, Araghi-Niknam M, Stary JM, Schulz SC, Lee S, Gottesman II (2004) Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia. Schizophr Res 69(2-3):317-323
20. Katsel P, Davis KL, Haroutunian V (2005) Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res 79(2-3):157-173
21. Volz HR, Riehemann S, Maurer I, Smesny S, Sommer M, Rzanny R, Holstein W, Czekalla J, Sauer H (2000) Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study. Biol Psychiatry 47(11):954-961
22. Gangadhar BN, Jayakumar PN, Subbakrishna DK, Janakiramaiah N, Keshavan MS (2004) Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-Phosphorus magnetic resonance spectroscopic study. Am J Psychiatry 161:1304-1306
23. Burbaeva GSh, Boksha IS, Turishcheva MS, Vorobyeva EA, Savushkina OK, Tereshkina EB (2003) Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27(4):675-680
24. Cavalier L, Jazin E, Eriksson I, Prince J, Båve B, Oreland L, Gyllensten U (1995) Decreased cytochrome-c oxidase activity and lack of age related accumulation of mtDNA in the brains of schizophrenics. Genomics 29:217-228
25. Prince JA, Oreland L (1998) Mitochondrial activity in the mapping of functional brain changes in schizophrenia. Restorative Neurol Neurosci 12(2-3):185-193
26. Maurer I, Zierz S, Moller H (2001) Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 48(1):125-136
27. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, Yolken RH (2000) Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 5(2):142-149
28. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E (2000) Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57(11):1061-1069
29. Tereshkina EB, Boksha IS, Savushkina OK, Burbaeva GSh (2000) [Glutamine synthetase and related protein in the frontal cortex in schizophrenia] Zh Nevrol Psikhiatr Im S S Korsakova 100(7):51-52
30. Knable MB, Torrey EF, Webster MJ, Bartko JJ (2001) Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 55(5):651-659
31. Tamminga CA (2006) The neurobiology of cognition in schizophrenia. J Clin Psychiatry 76(Suppl. 9):9-13
32. Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F, Matthey M-L, Parnas J, Preisig M, Saraga M, Solida A, Timm S, Wang AG, Werge T, Cuénod M, Do KQ (2006) Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Human Genet 79(3):587-592
33. McCullumsmith RE, Meador-Woodruff JH (2002) Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 26(3):368-375
34. Mendrek A, Laurens KR, Kiehl KA, Ngan ET, Stip E, Liddle PF (2004) Changes in distributed neural circuitry function in patients with first-episode schizophrenia. Br J Psychiatry 185:205-214
35. Gupta DS, McCullumsmith RE, Beneyto M, Haroutunian V, Davis KL, Meador-Woodruff JH (2005) Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia. Synapse 57(3):123-131
36. Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V (2004) GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res 76(4):581-592
37. Burbaeva GSh, Savushkina OK, Boksha IS (2003) Creatine kinase BB in brain in schizophrenia. World J Biol Psychiatry 4(4):177-183
38. Ross GW, O'Callaghan JP, Sharp DS, Petrovitch H, Miller DB, Abbott RD, Nelson J, Launer LJ, Foley DJ, Burchfiel CM, Hardman J, White LR (2003) Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease. Acta Neurol Scand 107(5):318-323
39. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265-275
40. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76(9):4350-4354
41. Boksha IS, Tereshkina EB, Burbaeva GSh (2000) Glutamine synthetase and glutamine synthetase-like protein from human brain: purification and comparative characterization. J Neurochem 75(6):2574-2582
42. Burbaeva GSh, Turishcheva MS, Vorobyeva EA, Savushkina OK, Tereshkina EB, Boksha IS (2002) Diversity of glutamate dehydrogenase in human brain. Prog Neuropsychopharmacol Biol Psychiatry 26(3):427-435
43. McInnes LA, Lauriat TL (2006) RNA metabolism and dysmyelination in schizophrenia. Neurosci Biobehav Rev 30(4):551-561
44. Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V (2006) Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol Dis 21(3):531-540
45. Burbaeva GSh, Boksha IS, Tereshkina EB, Savushkina OK, Starodubtseva LI, Turishcheva MS (2005) Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients. Neurochem Res 30(11):1443-1451
46. Krystal JH, D'Souza DC, Petrakis IL, Belger A, Berman RM, Charney DS, Abi-Saab W, Madonick S (1999) NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry 7(3):125-143
47. Burbaeva GSh, Boksha IS, Tereshkina EB, Savushkina OK, Turishcheva MS, Starodubtseva LI, Brusov OS, Morozova MA (2006) Effect of olanzapine treatment on platelet glutamine synthetase-like protein and glutamate dehydrogenase immunoreactivity in schizophrenia. World J Biol Psychiatry 7(2):75-81
48. Boksha IS (2004) Coupling between neuronal and glial cells via glutamate metabolism in brain of healthy persons and patients with mental disorders. Biochemistry (Mosc) 69(7):705-719
49. Toro CT, Hallak JE, Dunham JS, Deakin JF (2006) Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neurosci Lett 404(3):276-281